Blepharospasm management that addresses both reducing eyelid spasms and protecting the cornea is:

Prepare for the NBEO Part III Test with comprehensive questions on Patient Encounters and Performance Skills. Answer multiple choice and scenario-based questions with explanations. Ensure success on your optometry exam!

Multiple Choice

Blepharospasm management that addresses both reducing eyelid spasms and protecting the cornea is:

Explanation:
Blepharospasm management must address two goals at once: lessen the involuntary eyelid spasms and safeguard the corneal surface. Botulinum toxin injections into the eyelid muscles reduce the spasms by weakening the orbicularis oculi, which often leads to improved eyelid stability and blinking patterns. But reducing spasms can allow more lid opening, increasing exposure risk to the cornea. A protective approach like PFATs helps shield the cornea from drying and mechanical irritation, preserving surface integrity. Using both strategies targets both problems—lowering spasms and protecting the cornea—making this combination the most effective overall. The other options don’t simultaneously address spasm reduction and corneal protection.

Blepharospasm management must address two goals at once: lessen the involuntary eyelid spasms and safeguard the corneal surface. Botulinum toxin injections into the eyelid muscles reduce the spasms by weakening the orbicularis oculi, which often leads to improved eyelid stability and blinking patterns. But reducing spasms can allow more lid opening, increasing exposure risk to the cornea. A protective approach like PFATs helps shield the cornea from drying and mechanical irritation, preserving surface integrity. Using both strategies targets both problems—lowering spasms and protecting the cornea—making this combination the most effective overall. The other options don’t simultaneously address spasm reduction and corneal protection.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy